Position in MLTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,396,323
+$6,324,019 QoQ
Shares Held
328,522
+8369.2% QoQ
Ownership
0.386%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 172 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLTX Over Time
Shares Held
Position Value (USD)
Derivatives in MLTX
reported options exposure · as of Sep 30, 2023CallValue
$0
CallShares
0
PutValue
$1,812,600
PutShares
31,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. MLTX ranks #131 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in MLTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,396,323 | 328,522 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $72,304 | 3,879 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,150,283 | 239,020 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $604,767 | 84,347 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,792,519 | 80,350 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,718,444 | 120,769 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,511,759 | 27,918 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $319,661 | 6,340 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $143,649 | 3,267 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $740,992 | 14,752 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $38,709 | 641 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $64,125 | 1,125 | Shares | Defined | 2023-11-09 | |
| 2023-09-30 | $1,812,600 | 31,800 | Put | Defined | 2023-11-09 | |
| 2023-03-31 | $170,263 | 7,960 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $770,574 | 73,388 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $587,152 | 75,664 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $386,714 | 73,660 | Shares | Sole | 2022-08-10 | |
| No filing history on record for this holder in this stock. | ||||||